Skip to content
Disclosery

Eleva Capital SAS: NVDA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Eleva Capital SAS on NVDA, newest first. How the timeline and the estimate are built.

Eleva Capital SAS held 7,179 NVDA shares at 2026-09-30 per its 13F-HR filed 2026-10-06.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 7,179 shares
    Change vs previous 13F -44,823 shares

    1.45% of the 13F portfolio, value $1,639,540.

    13F-HR 0002054496-26-000005 filed by Eleva Capital SAS
    Accepted , ingested

  2. period ended2026-06-30
    13F 52,002 shares
    Change vs previous 13F 0 shares

    2.64% of the 13F portfolio, value $9,069,148.

    13F-HR 0002054496-26-000003 filed by Eleva Capital SAS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 52,002 shares
    Change vs previous 13F +52,002 shares

    2.64% of the 13F portfolio, value $9,069,148.

    13F-HR 0002054496-26-000002 filed by Eleva Capital SAS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -41,596 shares

    13F-HR 0002054496-25-000005 filed by Eleva Capital SAS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2025-06-30
    13F 41,596 shares
    Change vs previous 13F not available

    1.42% of the 13F portfolio, value $6,571,752.

    13F-HR 0002054496-25-000002 filed by Eleva Capital SAS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).